Ending Medicaid Discrimination Against the Most Vulnerable Act

Bill Number

H.R. 3321

Origin Chamber

House

Congress

119th Congress, Session 1

Policy Area

Health

Status

Introduced

Latest Action

2025-05-09: Referred to the House Committee on Energy and Commerce.

Last Updated

2025-06-18T08:05:47Z

AI-Generated Summary

Purpose of the Legislation

This bill, titled the "Ending Medicaid Discrimination Against the Most Vulnerable Act," aims to gradually eliminate the higher federal funding rate (known as the enhanced Federal Medical Assistance Percentage, or FMAP) that states receive for providing Medicaid health coverage to low-income adults who became newly eligible under the Affordable Care Act (ACA). The goal is to transition this funding to the standard FMAP rates that apply to other Medicaid groups, such as children and elderly individuals, over a period of about 10 years starting in 2027.

Key Provisions

• Phase-Out Schedule for Enhanced FMAP:
• The enhanced 90% federal funding rate for newly eligible low-income adults (those with incomes up to 138% of the federal poverty level) continues through 2026.
• From 2027 to 2034, the rate decreases annually by a state-specific amount: the difference between 90% and the state's regular FMAP for 2026, divided by 8. The rate cannot drop below the state's regular FMAP.
• Starting in 2035, the enhanced rate is fully eliminated, and states revert to their standard FMAP (typically 50-76% federal funding, based on state wealth).

• Rules for Non-Expansion and Expansion States:
• "Non-expansion states" (those that have not adopted the ACA's Medicaid expansion for low-income adults as of the bill's enactment) are not subject to the enhanced FMAP and would receive only the regular FMAP if they choose to expand later.
• "Expansion states" (those that have already expanded) can opt to limit coverage under the enhanced rate to adults with incomes up to 100% of the federal poverty level, while providing regular FMAP coverage for those between 100% and 138% of the poverty level.

• Elimination of Temporary Incentive:
• Removes a provision that provided a temporary 100% federal funding rate for states newly expanding Medicaid coverage to low-income adults.

Significant Changes to Existing Law

• Amends Section 1905(y) of the Social Security Act, which established the enhanced FMAP under the ACA in 2010. This change reverses the permanent 90% funding incentive for expansion populations, introducing a structured phase-out instead.
• Strikes Section 1905(ii), ending the short-term 100% federal match for new expansions, which was designed to encourage more states to participate.
• Introduces state flexibility for expansion states to cap enhanced funding at lower income levels (100% of poverty), potentially allowing partial retention of higher federal support.

Potential Impacts

• On Government Agencies: The Centers for Medicare & Medicaid Services (CMS) would need to adjust funding calculations and oversight for all states, potentially reducing federal Medicaid spending by billions over time as the enhanced match ends. States, especially the 40 that have expanded Medicaid, may face increased budget pressures to cover the shortfall (up to 40% more state costs by 2035).
• On Citizens: Low-income adults in expansion states could see reduced access to Medicaid if states cut coverage or eligibility to manage costs, affecting an estimated 15-20 million people. Other Medicaid groups (e.g., children, disabled individuals) might indirectly benefit from more equitable federal funding distribution.
• On International Relations: No direct impact, as this is a domestic health policy matter.

Main Stakeholders Affected

• States and State Governments: Particularly expansion states like California and New York, which rely on the enhanced FMAP to cover expansion populations; non-expansion states (e.g., Texas, Florida) are less directly affected but could face incentives or barriers to future expansion.
• Low-Income Adults: Newly eligible Medicaid enrollees (ages 19-64 without children or disabilities) who depend on the ACA expansion for affordable health coverage.
• Federal Government and Taxpayers: Reduced federal outlays could lower national spending but shift more costs to states, potentially straining overall healthcare affordability.
• Healthcare Providers and Insurers: Hospitals and clinics serving Medicaid patients may experience revenue drops if enrollment declines, affecting uncompensated care in underserved areas.

Notable Legal, Constitutional, or Political Implications

• Legal: The bill exercises Congress's authority under the Spending Clause of the U.S. Constitution to modify federal funding for state programs like Medicaid. It could face challenges if seen as coercive to states, similar to past ACA litigation (e.g., NFIB v. Sebelius, 2012), but the phase-out provides time for adjustment, potentially reducing legal vulnerabilities.
• Constitutional: No direct conflicts anticipated, as it aligns with federal control over interstate commerce and welfare spending; however, it may raise equal protection concerns if the phase-out disproportionately affects certain states or populations.
• Political: Introduced by Republican representatives, it reflects ongoing efforts to repeal or alter ACA provisions, potentially deepening partisan divides on healthcare policy. If enacted, it could influence state budgets and midterm elections, while encouraging states to innovate coverage options outside traditional Medicaid.

This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.

Sponsor

Rep. Roy, Chip [R-TX-21]

Cosponsors (19)

Rep. Fitzgerald, Scott [R-WI-5], Rep. Gill, Brandon [R-TX-26], Rep. Ogles, Andrew [R-TN-5], Rep. Spartz, Victoria [R-IN-5], Rep. Donalds, Byron [R-FL-19], Rep. Cloud, Michael [R-TX-27], Rep. Harris, Andy [R-MD-1], Rep. Boebert, Lauren [R-CO-4], Rep. Self, Keith [R-TX-3], Rep. Higgins, Clay [R-LA-3], Rep. Brecheen, Josh [R-OK-2], Rep. Perry, Scott [R-PA-10], Rep. Gosar, Paul A. [R-AZ-9], Rep. Tiffany, Thomas P. [R-WI-7], Rep. Biggs, Andy [R-AZ-5], Rep. Burlison, Eric [R-MO-7], Rep. Clyde, Andrew S. [R-GA-9], Rep. Norman, Ralph [R-SC-5], Rep. Miller, Mary E. [R-IL-15]

Recent Actions

• 2025-05-09: Referred to the House Committee on Energy and Commerce.
• 2025-05-09: Introduced in House
• 2025-05-09: Introduced in House

Bill Versions

• Ending Medicaid Discrimination Against the Most Vulnerable Act — issued 2025-05-09 — PDF (5 pages)